Insider Selling: LifeStance Health Group (NASDAQ:LFST) Major Shareholder Sells $144,890,858.34 in Stock

LifeStance Health Group, Inc. (NASDAQ:LFST) major shareholder Tpg Gp A, Llc sold 13,643,207 shares of the stock in a transaction on Monday, August 10th. The shares were sold at an average price of $10.62, for a total value of $144,890,858.34. Following the completion of the transaction, the insider directly owned 98,101,407 shares in the company, valued at $1,041,836,942.34. This trade represents a 12.21% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Large shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

LifeStance Health Group Price Performance

LFST stock opened at $12.42 on Friday. The business has a 50 day moving average price of $10.39 and a 200 day moving average price of $8.22. The company has a quick ratio of 1.38, a current ratio of 1.38 and a debt-to-equity ratio of 0.18. The stock has a market cap of $4.82 billion, a price-to-earnings ratio of 95.55 and a beta of 1.14. LifeStance Health Group, Inc. has a fifty-two week low of $4.77 and a fifty-two week high of $12.76.

LifeStance Health Group (NASDAQ:LFST) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.06 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.03. The business had revenue of $435.35 million during the quarter, compared to the consensus estimate of $414.58 million. LifeStance Health Group had a net margin of 3.19% and a return on equity of 3.39%. The company’s revenue was up 26.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.01) EPS. Equities research analysts anticipate that LifeStance Health Group, Inc. will post 0.15 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have weighed in on LFST. Wall Street Zen upgraded LifeStance Health Group from a “buy” rating to a “strong-buy” rating in a research note on Saturday. BTIG Research lifted their target price on shares of LifeStance Health Group from $15.00 to $16.00 and gave the company a “buy” rating in a report on Friday, August 7th. KeyCorp upped their price target on shares of LifeStance Health Group from $11.00 to $13.00 and gave the company an “overweight” rating in a research report on Monday, July 13th. JPMorgan Chase & Co. increased their price target on shares of LifeStance Health Group from $9.00 to $13.00 and gave the stock a “neutral” rating in a research note on Friday. Finally, Zacks Research lowered shares of LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 13th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $12.12.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Assetmark Inc. lifted its holdings in shares of LifeStance Health Group by 17.0% during the first quarter. Assetmark Inc. now owns 9,419 shares of the company’s stock worth $60,000 after purchasing an additional 1,367 shares during the period. California State Teachers Retirement System increased its stake in LifeStance Health Group by 1.6% in the 4th quarter. California State Teachers Retirement System now owns 125,682 shares of the company’s stock valued at $885,000 after buying an additional 1,966 shares during the period. Vident Advisory LLC increased its stake in LifeStance Health Group by 12.7% in the 2nd quarter. Vident Advisory LLC now owns 21,732 shares of the company’s stock valued at $112,000 after buying an additional 2,447 shares during the period. Xponance LLC raised its position in LifeStance Health Group by 26.4% during the 4th quarter. Xponance LLC now owns 13,144 shares of the company’s stock worth $93,000 after buying an additional 2,745 shares during the last quarter. Finally, Diversified Trust Co raised its position in LifeStance Health Group by 14.8% during the 1st quarter. Diversified Trust Co now owns 21,532 shares of the company’s stock worth $137,000 after buying an additional 2,770 shares during the last quarter. Institutional investors and hedge funds own 85.50% of the company’s stock.

LifeStance Health Group Company Profile

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.